Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (Stroke08)

This study has been completed.

Sponsor:

Information provided by:

Klinikum Ludwigshafen

ClinicalTrials.gov Identifier:

NCT00812656

First received: December 19, 2008

Last updated: December 2, 2009

Last verified: December 2009

History of Changes

Purpose

The purpose of this study is to investigate changes in new plasma stroke biomarker panel in patients undergoing cardiac surgery with the use of cardiopulmonary bypass.

Condition
Cardiac Surgery


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Resource links provided by NLM:

MedlinePlus related topics: Heart Surgery

U.S. FDA Resources

Further study details as provided by Klinikum Ludwigshafen:

Primary Outcome Measures:

Change in stroke index [ Time Frame: day before surgery; first and second day postoperatively ]


Enrollment:	50
Study Start Date:	December 2008
Study Completion Date:	December 2009
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts
Stroke Panel group Patients undergoing cardiac surgery with the use of cardiopulmonary bypass

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Adult patients undergoing cardiac surgery with the use of cardiopulmonary bypass

Criteria

Inclusion Criteria:

Age > 18 years
Elective cardiac surgery with the use of cardiopulmonary bypass

Exclusion Criteria:

Patients undergoing emergent procedures
Patients with preoperative mechanical support

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00812656

Locations


Germany
Klinikum Ludwigshafen
Ludwigshafen, RLP, Germany, 67063

Sponsors and Collaborators

Klinikum Ludwigshafen

Investigators


Principal Investigator:	Stefan W Suttner, MD	Klinikum Ludwigshafen

More Information


Responsible Party:	Prof. Dr. J. Boldt, Klinikum Ludwigshafen
ClinicalTrials.gov Identifier:	NCT00812656 History of Changes
Other Study ID Numbers:	StrokePanel08
Study First Received:	December 19, 2008
Last Updated:	December 2, 2009

ClinicalTrials.gov processed this record on August 18, 2017

To Top